CD8A and neuroblastoma: We found that Syk blockade stimulated T cell recruitment into NB tumors as CD3+ and CD8+ T cell content was significantly increased in the tumors implanted in SykMC-KO mice and in NB9464 tumors treated with R788 (Figures 3B–E).